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Abstract
Background: Small lymphocytic lymphoma is a relatively rare B-cell non-Hodgkin lymphoma that is considered
to be the tissue equivalent of the much more common entity chronic lymphocytic leukemia. Cutaneous
manifestations of small lymphocytic lymphoma are infrequent and the literature regarding them sparse. We
describe here a case of a patient with a history of small lymphocytic lymphoma who developed perniosis-like
features of the digits.
Case presentation: An 86-year old male patient with previously diagnosed small lymphocytic lymphoma
developed painful erythematous swelling of the periungual area of his fingers and toes. This was associated with a
dense dermal infiltration of CD5-positive B-lymphoid cells consistent with his low-grade B-cell lymphoma. Although
partially refractory to local radiotherapy, the painful swelling of the fingers and toes resolved fully following
systemic therapy with chlorambucil and rituximab.
Conclusions: This unusual cutaneous manifestation of a lymphoma and the favourable response to systemic
therapy may be instructive for the management of other patients who develop similar perniosis-like features.
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Background
Small lymphocytic lymphoma (SLL), the tissue equiva-
lent of chronic lymphocytic leukemia (CLL), typically
presents with lymphadenopathy, organomegaly, and the
presence of infiltrating monoclonal B cells having the
same immunophenotype as CLL cells but lacking periph-
eral blood lymphocytosis [1]. The dermatological litera-
ture relating to SLL and CLL is sparse. We report a case
of perniosis-like involvement of the digits in a patient with
SLL and review the literature regarding cutaneous mani-
festations of SLL and CLL.
Case presentation
The patient is an 86-year-old male who presented in 2004
with small nodules on both ears. There was no palpable
lymphadenopathy or splenomegaly noted on physical
examination. A biopsy of one of these nodules showed
widespread infiltration of small, mature lymphoid cells with
occasional proliferation centres. Immunohistochemistry
revealed the majority of cells to be CD5, CD20 positive
and CD 3 and cyclin D1 negative. The peripheral blood
showed a white blood cell count (WBC) of 6.9 × 109/L
(4–10.5), neutrophils 4.44 × 109/L (2.00-7.00), lym-
phocytes 1.89 × 109/L (1.50-4.0), haemoglobin 145 g/L
(136–170) and platelets 307 × 109/L (150–400). The
remainder of the leukocyte differential was unremarkable.
A blood smear showed normal appearing lymphocytes
with occasional reactive form but no smudge cells or plas-
macytoid features. A bone marrow biopsy showed a subtle
interstitial small lymphoid infiltration with mature chro-
matin and no plasmacytoid differentiation constituting
less than 20 % of the marrow. Immunophenotyping by
flow cytometry performed on the bone marrow confirmed
a lambda monoclonal B-cell proliferation with dim surface
immunoglobulin expression and CD5 and CD19 co-
expression. CD20 expression was evident but CD10,
CD23 and FMC7 staining was absent. Conventional
karyotype analysis was not performed, but fluorescence in
situ hybridization was negative for the CCND1-IGH
fusion gene created by the t(11;14). The findings from the
ear lobe biopsy, peripheral blood and bone marrow biopsy
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were thought to be most consistent with a diagnosis
of SLL.
In 2007, the patient developed jaundice and abdominal
pain due to choledocholithiasis and underwent a chole-
cystectomy. In addition to cholelithiasis, there was a
background population of B-lymphocytes co-expressing
CD5 and CD20 with no evidence of CD23, CD10 or
cylcin D1 expression. A liver biopsy performed the same
year to investigate abnormal liver function tests showed
marked lymphocytic and plasmacytic infiltration as well
as reactive secondary follicles predominately involving
the portal tracts, suggestive of autoimmune hepatitis but
with an unusual degree of lymphocyte infiltration with
the same phenotypic profile as the gallbladder. The pa-
tient was treated with azathioprine with a normalization
of his liver function tests and symptoms. He was re-
ferred to the British Columbia Cancer Agency in July
2012 because of painful erythematous bulging of the
periungual areas of all his fingers (Fig. 1, upper panel)
and toes. Physical examination revealed palpable lymph-
adenopathy in the left anterior cervical chain, the axillae
and the left groin, with the largest lymph gland esti-
mated to be one centimeter in greatest diameter. Spleno-
megaly was not detected. A biopsy of the affected skin
from the right second finger showed a dense and rela-
tively monomorphic infiltration of the superficial and
deeper dermis, by small to intermediate sized lym-
phocytes with condensed chromatin, irregular nuclear
contours and minimal cytoplasm (Fig. 2, a and b). Im-
munohistochemistry confirmed the vast majority of the
infiltrate to be of B-lymphoid lineage with these cells
aberrantly co-expressing CD20 and CD5 (while being
CD10-, 23-, 43-, and cyclin D1-negative) (Fig. 2, c and d).
These features were in keeping with a low-grade B-cell
lymphoma, such as small lymphocytic lymphoma. The pa-
tient received radiation to the fingers and thumbs without
any significant improvement. The right third, fourth and
fifth fingers were re-irradiated in September 2012 but
again with only a slight improvement. A serum protein
electrophoresis showed a marked polyclonal IgG and IgA
hypergammaglobulinemia, with a normal IgM level of
0.74 g/L (0.5-2.00). There was a significant increase in the
serum viscosity but only a mild increase in the liver ami-
notransferase enzymes.
The patient was started on chlorambucil and rituxi-
mab in April 2013 and received a total of 6 cycles. The
serum immunoglobulin levels decreased significantly
with each treatment cycle, as did the swelling and pain
in the fingers (Fig. 1, lower panel) and toes. The serum
viscosity level and the liver function tests returned to
their normal ranges. A rise in the liver function tests in
the fall of 2014 was not accompanied by any progression
Fig. 1 Upper panel: Bilateral periungual swelling of the fingers. Lower panel: Images of the fingers after six cycles of chlorambucil and rituximab
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of the dermopathy or significant change in the serum
immunoglobulins. It was treated successfully with a 3-
month course of oral budesonide. The patient was last
seen in February 2015, at which time there was no re-
currence of the abnormalities of the digits, no progres-
sion of the gammopathy, and his serum viscosity and
liver enzymes were within the normal range.
Discussion
The patient discussed in this report developed an un-
usual dermatological manifestation of a low-grade B-cell
lymphoma. The histology and immunophenotype of the
ear, finger and bone marrow biopsies, together with the
patient’s indolent course are consistent with a diagnosis
of small lymphocytic lymphoma (SLL). Although CD23
expression is usually seen in CLL/SLL, CD23 negative
cases are not rare [2]. The negative FMC7 and cyclin D1
expression and absent t(11;14) virtually excludes the
diagnosis of mantle cell lymphoma. Furthermore, mantle
cell lymphoma usually follows a more aggressive course
while our patient had a very indolent course, only re-
quiring treatment because of his painful fingers. Expres-
sion of SOX11 is seen in the majority of MCL cases [3].
If our case was clinically, morphologically and immu-
nophenotypically suspicious for MCL but cyclin D1
expression negative, then testing for SOX11 expression
may have been useful in ruling out a diagnosis of
MCL. Lymphoplasmacytic lymphoma (LPL) can rarely
be CD5-positive. However, our case did not show plas-
macytoid cytologic features and demonstrated surface
immunoglobulin expression dimmer than would be
expected in LPL. FMC7 was also negative and an IgM
paraprotein was never detected [2]. The appearance of
the monoclonal lymphoid infiltrates seen in the biopsies
without the typical clear abundant cytoplasm often ob-
served in marginal zone lymphoma, together with the
positive CD5 expression and negative FMC7 seen in this
case make a diagnosis of marginal zone lymphoma less
likely as well. However, CD5-postive marginal zone
lymphomas have been reported [4, 5].
Dermatologic manifestations are relatively uncommon
in SLL and CLL. Estimated incidences are in the range
of 4 to 45 %, but most of the previously reported reviews
included cases where the skin was infiltrated with B-
lymphocytes and other non-lymphoid malignancies and
nonmalignant disorders associated with CLL/SLL [6, 7].
The cutaneous manifestations of CLL/SLL infiltrating
the skin include small or large tumour nodules, papules,
plaques and erythroderma. Infiltrates may be solitary,
grouped or generalized [6, 7]. With regard to the current
Fig. 2 Micrograph prepared from periungual biopsy of right second finger. a, H&E x 40 - Low power view of micrograph prepared from
periungual biopsy of right second finger, showing diffuse dermal infiltration by monomorphous lymphoid infiltrate, typical of SLL/CLL. b, H&E x
400 - Detail of uniform small lymphocytes with round nuclei, condensed chromatin and scanty cytoplasm. c, CD20 - The lesional cells are
uniformly positive for CD20. d, CD5 - The CD20 + cells show aberrant weak positivity for CD5. Note the scattered T-cells that stain more strongly
for CD5
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patient, the gross appearance of his digits was similar to
perniosis (chilblains). A handful of reports describing a
perniosis-like presentation with leukemia cutis have ap-
peared in the literature; however, these have typically
been associated with myelomonocytic leukemias rather
than lymphoid malignancies [8–11]. SLL with secondary
cutaneous involvement needs to be differentiated from
primary cutaneous B-cell lymphoma, which is com-
prised of three main types: primary cutaneous marginal
zone B-cell lymphoma, primary cutaneous follicle cen-
ter lymphoma, and primary cutaneous large B-cell
lymphoma (leg type) [12, 13]. Primary cutaneous mar-
ginal zone B-cell and follicle center lymphoma are in-
dolent types with excellent prognoses. These should
be treated with nonaggressive therapies, whereas pri-
mary cutaneous large B-cell lymphoma (leg type) is
often a rapidly growing tumour requiring aggressive
chemotherapy.
In patients with SLL or CLL, Richter’s syndrome (RS),
the development of high-grade NHL, can occur. RS oc-
curs in 3-10 % of cases and may be triggered by viral in-
fections (e.g. Epstein-Barr virus infection) or acquisition
of additional genetic abnormalities [14, 15]. The disease
commonly involves the lymph nodes, bone marrow and
viscera, with rare skin manifestations. When cutaneous
symptoms arise, they may include erythematous papules,
nodules, or plaques involving the face, back, and chest.
Although clinical data are limited, cutaneous RS gener-
ally has a less aggressive course with longer survival than
extracutaneous RS [15].
The most commonly reported non-lymphoid malig-
nant cutaneous conditions frequently associated with
SLL/CLL consist of skin cancers (basal cell carcinoma,
squamous cell carcinoma, malignant melanoma, Merkel
cell carcinoma, and mycosis fungoides), viral infections
(varicella-zoster, herpes simplex, and viral warts), and
acute graft-versus-host disease [7, 16, 17]. Basal cell and
squamous cell carcinomas as well as melanoma can
develop prior to any therapeutic immunosuppression,
indicating a predisposition inherent to B-cell malig-
nancies. Perhaps this is due to the coincident abnormal
T-cell function and impaired responses of B-lymphocytes
to mitogens and growth factors.
Prior to diagnosis of hematologic malignancies such as
SLL and CLL, exaggerated cutaneous hypersensitivity,
including reactions to mosquito and other arthropod
bites can be observed [18, 19]. These hypersensitivity re-
actions must be distinguished from lymphocytoma cutis
(LC), or cutaneous lymphoid hyperplasia, the stereotyp-
ical example of the cutaneous B-cell pseudolymphoma.
This can similarly be induced by various antigenic
stimuli, including arthropod bites, ingestion of drugs, al-
lergy hyposensitization injections or vaccination, chronic
infections, and tattoo pigment [20, 21]. By contrast,
cutaneous disease observed at sites of previous herpes
simplex and herpes zoster infections in CLL/SLL pa-
tients represents specific infiltration by leukemia cells,
rather than LC [22]. In endemic regions, Borrelia
burgdorferi, the spirochete responsible for Lyme dis-
ease, is the predominant causative agent for LC and
is associated most commonly with sites of involve-
ment including the nipple, genital area, and earlobe
[23]. Of note, cases of primary cutaneous B-cell
lymphoma associated with B. burgdorferi infection
have been described, and in patients with CLL this
infection can trigger the development of specific cuta-
neous malignant infiltrates at typical sites of involve-
ment for LC [24, 25].
An additional skin disease associated with CLL and
malignant B-cell lymphomas is paraneoplastic pem-
phigus (PNP), a recently characterized rare autoimmune
vesiculobullous eruption producing painful mucocutane-
ous ulcerations in patients [26]. This poor-prognosis
blistering disorder is associated with antibodies targeted
against proteins of keratinocyte adhesion, thereby caus-
ing acantholysis. Clinical findings include oral erosions
and flaccid cutaneous bullae and erosions. Retrospective
uncontrolled studies suggest that immunosuppressive
agents reduce mortality in pemphigus, and the anti-
CD20 monoclonal antibody rituximab may be an effect-
ive treatment for refractory patients [26]. Treating the
underlying malignancy with chemotherapy may help to
control autoantibody production. Interestingly, how-
ever, fludarabine, a purine analog chemotherapy agent
with substantial activity in CLL and indolent NHL,
may be associated with the induction of PNP in some
cases [27].
Additional conditions associated with periungual
swelling include acute and chronic paronychia, clubbing
and pseudoclubbing, amyloid arthopathy, and the cuta-
neous involvement associated with lupus, scleroderma,
dermatomyositis and other connective tissue diseases;
however, neither the history nor clinical presentation of
the patient reported herein are consistent with any of
these disorders [28–31].
Conclusions
We present a case of SLL with a previously unreported
complication demonstrating perniosis-like features in-
volving the fingers and toes. The infiltration of the
periungual areas with lymphoma cells was confirmed by
histopathology findings. The contribution of the poly-
clonal hypergammaglobulinemia and hyperviscosity to
the periungual changes is not clear. The complete reso-
lution of the perniosis-like features after treatment with
chemotherapy and rituximab immunotherapy may be
instructive for the management of other patients who
develop this disease manifestation.
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